Immunocore Holdings PLC (NAS:IMCR)
$ 46.05 -1.93 (-4.02%) Market Cap: 2.30 Bil Enterprise Value: 1.85 Bil PE Ratio: 0 PB Ratio: 5.07 GF Score: 73/100

Immunocore Holdings PLC PRAME Investor and Analyst Event AT ESMO 2022 Transcript

Sep 09, 2022 / 04:30PM GMT
Release Date Price: $44.75 (-22.09%)
Clayton Robertson
Immunocore Holdings PLC - Head of IR

(audio already in progress) to discuss the Phase 1 data from Immunocore's PRAME program. Before I begin, before we begin, I'd like to read some forward-looking statements.

During today's presentation, we'll be making certain forward-looking statements, including about development activities, business strategy, and the timing and impact of future events. Actual results could differ materially from those projected by these statements, which are based on management's views as of today and subject to risks and uncertainties, including those noted on most recent Form 20-F and in the 6-K we filed with the SEC. You're cautioned not to place undue reliance on these statements Immunocore disclaims any obligation to update them. We will also discuss non-IFRS measures in today's presentation, which is reconciled to the comparable IFRS measure in today's slides.

I'm now pleased to introduce our CEO, Dr. Bahija Jallal.

Bahija Jallal
Immunocore Holdings PLC - CEO

Thank you, Clay, and good evening,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot